Return on Equity: The amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested. Calculated as: Income from Continuing Operations / Total Common Equity
Sensei Biotherapeutics, Inc. (SNSE) had Return on Equity of -19.86% for the most recently reported fiscal quarter, ending 2025-09-30.
| Income Statement Financials | |
-- |
|
$-4.57M |
|
-- |
|
-- |
|
$4.85M |
|
$-4.85M |
|
$0.28M |
|
$-4.57M |
|
$-4.57M |
|
$-4.57M |
|
$-4.57M |
|
$-4.57M |
|
$-4.57M |
|
$-4.85M |
|
$-4.82M |
|
1.26M |
|
1.26M |
|
$-3.62 |
|
$-3.62 |
|
| Balance Sheet Financials | |
$25.79M |
|
$0.11M |
|
$1.80M |
|
$27.59M |
|
$4.44M |
|
-- |
|
$0.15M |
|
$4.58M |
|
$23.01M |
|
$23.01M |
|
$23.01M |
|
1.26M |
|
| Cash Flow Statement Financials | |
$-16.59M |
|
$17.69M |
|
$-0.53M |
|
$9.99M |
|
$10.56M |
|
$0.57M |
|
$0.98M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
5.81 |
|
-- |
|
-- |
|
-- |
|
0.01 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-16.36M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
|
Return on Equity |
-19.86% |
-19.86% |
|
-16.56% |
|
-19.86% |
|
$18.25 |
|
$-12.97 |
|
$-13.16 |
|